Haller, M.E
While some may view these changes as a threat, we see opportunities for innovation and growth
Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
Drug interactions with other medications, for example, medicines that are part of your diabetic plan or other weight loss drugs
Some even claim to have Certificates of Authenticity, which perhaps they were missold to by a supplier of fake or illegal forms of Semaglutide
Let our knowledgeable providers in New Mexico evaluate whether tirzepatide is the right option for you